Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 FDA eases restrictions on the glucose-lowering drug rosiglitazone.

× No keyword cloud information.

5 in total

1. RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activity.

Authors: Masashi Mukohda; Shi Fang; Jing Wu; Larry N Agbor; Anand R Nair; Stella-Rita C Ibeawuchi; Chunyan Hu; Xuebo Liu; Ko-Ting Lu; Deng-Fu Guo; Deborah R Davis; Henry L Keen; Frederick W Quelle; Curt D Sigmund
Journal: J Clin Invest Date: 2019-03-21 Impact factor: 14.808

2. Disparities in Discontinuing Rosiglitazone Following the 2007 FDA Safety Alert.

Authors: Danya M Qato; Amal N Trivedi; Vincent Mor; David D Dore
Journal: Med Care Date: 2016-04 Impact factor: 2.983

3. Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus.

Authors: Tian Li; Rui Providencia; Nan Mu; Yue Yin; Mai Chen; Yishi Wang; Manling Liu; Lu Yu; Chunhu Gu; Heng Ma
Journal: Cardiovasc Diabetol Date: 2021-01-30 Impact factor: 9.951

Review 4. Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis.

Authors: Ratree Sawangjit; Bunchai Chongmelaxme; Pochamana Phisalprapa; Surasak Saokaew; Ammarin Thakkinstian; Kris V Kowdley; Nathorn Chaiyakunapruk
Journal: Medicine (Baltimore) Date: 2016-08 Impact factor: 1.889

5. Cardiomyocyte Overexpression of FABP4 Aggravates Pressure Overload-Induced Heart Hypertrophy.

Authors: Ji Zhang; Congzhen Qiao; Lin Chang; Yanhong Guo; Yanbo Fan; Luis Villacorta; Y Eugene Chen; Jifeng Zhang
Journal: PLoS One Date: 2016-06-13 Impact factor: 3.240

5 in total